Clinical trial
Immune Ablation and Hematopoietic Stem Cell Support in Patients With Systemic…
NCT00271934 · Northwestern University, Other · Completed
Key facts
| NCT number | NCT00271934 |
|---|---|
| Title | Immune Ablation and Hematopoietic Stem Cell Support in Patients With Systemic Lupus Erythematosus: A Phase II Study |
| Official title | Immune Ablation and Hematopoietic Stem Cell Support in Patients With Poor Prognostic Indicators and Systemic Lupus Erythematosus:A Phase II Study |
| Lead sponsor | Northwestern University, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Systemic Lupus Erythematosus |
| Intervention type | Biological |
| Interventions | Immune ablation and hematopoietic stem cell support. |
| Enrollment | 52 |
| Start date | Sep 1, 2002 |
| Primary completion | Nov 1, 2007 |
| Completion | Apr 1, 2012 |
| First posted | Jan 4, 2006 |
| Last update posted | Nov 9, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: